BREA, Calif., April 27, 2021 /PRNewswire/ — Envista Holdings Corporation (NYSE: NVST) (“Envista”) today declared the establishment of a new partnership aimed at offering value-extra methods and a wide range of expert services to Curaeos’ speedy-developing community of dental clinics across the Netherlands, Belgium, Denmark, Germany, and Italy.

Envista is focused on providing Curaeos’ clinics with the most up-to-date and most modern dental solutions readily available from its primary brand names like KaVo, Kerr, Nobel Biocare, and Ormco. The new partnership emphasizes Envista’s shared reason and motivation to support to empower Curaeos’ dental practitioners in their mission to provide high excellent dental care to their people, like entry to a broad array of education and academic plans and initiatives spearheaded by the Curaeos Academy.

Chris Cools, CEO Curaeos, shared his enthusiasm for the partnership, “On our journey to come to be a foremost European DSO and the very first preference for clients and dental treatment experts, we are dedicated to present a excellent affected individual working experience and provide our sufferers with oral care, offering the two top quality & convenience. To reach our objectives, we are incredibly joyful to be able to join forces with Envista who is renowned for its environment course products and providers.”

“We are on the lookout ahead to partnering with Curaeos to help the dental gurus inside their network,” Amir Aghdaei, CEO of Envista, stated.  “Curaeos’ know-how in supporting dental clinics blended with our modern portfolio of remedies will assistance produce a lot more predictable and successful results, major to excellent dental treatment for extra individuals.”

ABOUT ENVISTA HOLDINGS Company

Envista is a international family of much more than 30 dependable dental makes, united by a shared reason: to lover with pros to strengthen lives.  Envista allows its customers produce the finest achievable affected individual treatment by industry-leading dental consumables, solutions, engineering, and expert services.  Our comprehensive portfolio, such as dental implants and remedy solutions, orthodontics, and digital imaging systems, handles an believed 90% of dentists’ scientific wants for diagnosing, dealing with, and avoiding dental conditions as well as improving upon the aesthetics of the human smile.  Envista companies, including KaVo Kerr, Nobel Biocare, and Ormco, lover with dental specialists to assist them provide the best attainable affected individual treatment.  With a foundation comprised of the verified Envista Company Technique (EBS) methodology, an knowledgeable management crew, and a potent lifestyle grounded in continual enhancement, determination to innovation, and deep buyer emphasis, Envista is nicely equipped to fulfill the conclusion-to-conclusion wants of dental gurus worldwide.  Envista is one of the greatest world-wide dental items firms, with sizeable industry positions in some of the most interesting segments of the dental products sector.  For extra facts, you should visit www.envistaco.com.

Ahead-Searching STATEMENTS

Specified statements in this launch are “ahead-searching” statements inside the this means of the federal securities laws. There are a quantity of significant aspects that could lead to genuine benefits, developments and company conclusions to vary materially from these instructed or indicated by this kind of forward-wanting statements and you need to not location undue reliance on any such ahead-hunting statements. These components involve, amid other things, the affect of the COVID-19 pandemic, the circumstances in the U.S. and international economic climate, the marketplaces served by us and the monetary markets, the influence of our financial debt obligations on our operations and liquidity, developments and uncertainties in trade procedures and laws, contractions or growth charges and cyclicality of markets we serve, fluctuations in stock of our distributors and customers, decline of a crucial distributor, our interactions with and the effectiveness of our channel partners, levels of competition, our means to produce and successfully current market new products and products and services, the likely for improper conduct by our workers, agents or company partners, our compliance with relevant legal guidelines and restrictions (which include rules relating to healthcare gadgets and the overall health treatment business), the benefits of our medical trials and perceptions thereof, penalties connected with any off-label marketing of our products, modifications to our products and solutions that require new internet marketing clearances or authorizations, our capability to efficiently tackle expense reductions and other alterations in the wellness treatment industry, our capacity to effectively identify and consummate correct acquisitions and strategic investments, our means to integrate the corporations we purchase and reach the anticipated benefits of these types of acquisitions, contingent liabilities relating to acquisitions, investments and divestitures, sizeable restrictions and/or prospective liability dependent on tax implications of transactions with Danaher, stability breaches or other disruptions of our information technology devices or violations of knowledge privacy guidelines, our skill to adequately shield our intellectual home, the affect of our restructuring pursuits on our skill to mature, risks relating to forex trade premiums, alterations in tax regulations applicable to multinational corporations, litigation and other contingent liabilities which includes intellectual property and environmental, overall health and safety matters, risks relating to solution, provider or computer software problems, pitfalls relating to item production, commodity prices and surcharges, our skill to adjust purchases and manufacturing potential to replicate market place disorders, reliance on sole or constrained resources of supply, the impression of regulation on demand for our goods and providers, labor matters, global economic, political, lawful, compliance and business aspects,  and disruptions relating to war, terrorism, prevalent protests and civil unrest, male-produced and pure disasters, general public wellbeing troubles and other events. Further facts relating to the variables that might lead to real benefits to differ materially from these ahead-looking statements is accessible in our SEC filings, like our Annual Report on Form 10-K for fiscal 12 months 2019 and our Quarterly Reviews on Variety 10-Q. These forward-wanting statements speak only as of the date of this launch and apart from to the extent expected by applicable regulation, we do not think any obligation to update or revise any ahead-wanting statement, whether as a outcome of new details, foreseeable future gatherings and developments or normally.

Source Envista Holdings Company

FOR Even further Details

Melissa Morrison
Director, Conversation
Envista Holdings Corporation
200 S. Kraemer Blvd., Making E
Brea, CA 92821
Phone: (714) 817-7000
Fax: (714) 817-5450

Resource Envista Holdings Corporation

Associated Hyperlinks

http://www.envistaco.com